27 results on '"Narala S"'
Search Results
2. 273 Establishment of an autologous microbiome transplant in atopic dermatitis targeting Staphylococcus aureus
- Author
-
Nakatsuji, T., primary, Narala, S., additional, Chen, T.H., additional, Chun, K.A., additional, Hata, T., additional, and Gallo, R.L., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Clinicopathology of Middle Ear Tumours: A Retrospective Study from a Tertiary Care Hospital, Hyderabad, India
- Author
-
Narala Srivani and Thamidala Mahitha Joyce
- Subjects
haemangioma ,polyp ,schwannoma ,squamous cell carcinoma ,Medicine - Abstract
Introduction: Middle ear tumours are rare neoplasms that have non specific clinical presentation, otoscopic and imaging features and pose a diagnostic challenge. Most common neoplasm of middle ear are paraganglioma, schwannoma, haemangioma and middle ear adenoma. Aim: To analyse the relative incidence, clinical presentation and histopathological spectrum of neoplasms in the middle ear at a tertiary care hospital, Hyderabad, Telangana, India. Materials and Methods: This retrospective study was conducted in Department of Pathology at Government ENT Hospital (tertiary referral ENT Hospital), Hyderabad, Telangana, India, from July 2014 to June 2019. Total 26 cases of middle ear tumours both incisional or excisional biopsies of middle ear lesions from all age group of either gender with complete clinical details were included in the study. Clinical and histopathological data were analysed after processing the sections with Haematoxylin and Eosin (H&E) stains examined microscopically. Statistical analysis was done using Statistical Package for Social Science (SPSS) version 20.0 and mean, standard deviation and percentages were calculated. Results: In the present study, maximum patients 11 (42.3%) were in age group of 41 to 50 years with female preponderance 18 (69.2%). Mean age of the patients were 42.92±12.53 years. Out of a total of 26 cases, 20 cases were benign neoplasms and six cases were malignant. Most common side of presentation was right side. Most of the benign tumours occurred in the 5th decade and malignant tumours were common in the 6th decade. Paragangliomas/Glomustympanicum tumours were most common benign tumours followed by schwannoma, haemangioma and middle ear adenoma. Whereas among malignant tumour, squamous cell carcinoma was common. Conclusion: Middle ear tumours are relatively uncommon lesions presenting as mass in the ear, discharge, hearing loss, tinnitus and chronic suppurative otitis media. Benign tumours are more common than malignant tumours in the middle ear. Paraganglioma was the most common benign tumour encountered, followed by schwannomas, middle ear adenomas and haemangiomas. Middle ear tumours are rare and histologic analysis is essential for definitive diagnosis and treatment.
- Published
- 2022
- Full Text
- View/download PDF
4. Primary Hyperoxaluria in Cats Is Caused by a Mutation in the Feline GRHPR Gene
- Author
-
Goldstein, R. E., primary, Narala, S., additional, Sabet, N., additional, Goldstein, O., additional, and McDonough, S. P., additional
- Published
- 2009
- Full Text
- View/download PDF
5. Differential DNA damage repair and PARP inhibitor vulnerability of the mammary epithelial lineages.
- Author
-
Kim H, Aliar K, Tharmapalan P, McCloskey CW, Kuttanamkuzhi A, Grünwald BT, Palomero L, Mahendralingam MJ, Waas M, Mer AS, Elliott MJ, Zhang B, Al-Zahrani KN, Langille ER, Parsons M, Narala S, Hofer S, Waterhouse PD, Hakem R, Haibe-Kains B, Kislinger T, Schramek D, Cescon DW, Pujana MA, Berman HK, and Khokha R
- Published
- 2023
- Full Text
- View/download PDF
6. Twin Screw Melt Granulation: A Single Step Approach for Developing Self-Emulsifying Drug Delivery System for Lipophilic Drugs.
- Author
-
Nyavanandi D, Mandati P, Narala S, Alzahrani A, Kolimi P, Vemula SK, and Repka MA
- Abstract
The current research aims to improve the solubility of the poorly soluble drug, i.e., ibuprofen, by developing self-emulsifying drug delivery systems (SEDDS) utilizing a twin screw melt granulation (TSMG) approach. Gelucire
® 44/14, Gelucire® 48/16, and Transcutol® HP were screened as suitable excipients for developing the SEDDS formulations. Initially, liquid SEDDS (L-SEDDS) were developed with oil concentrations between 20-50% w / w and surfactant to co-surfactant ratios of 2:1, 4:1, 6:1. The stable formulations of L-SEDDS were transformed into solid SEDDS (S-SEDDS) using a suitable adsorbent carrier and compressed into tablets (T-SEDDS). The S-SEDDS has improved flow, drug release profiles, and permeability compared to pure drugs. The existence of the drug in an amorphous state was confirmed by differential scanning calorimetry (DSC) and powder X-ray diffraction analysis (PXRD). The formulations with 20% w / w and 30% w / w of oil concentration and a 4:1 ratio of surfactant to co-surfactant have resulted in a stable homogeneous emulsion with a globule size of 14.67 ± 0.23 nm and 18.54 ± 0.55 nm. The compressed tablets were found stable after six months of storage at accelerated and long-term conditions. This shows the suitability of the TSMG approach as a single-step continuous manufacturing process for developing S-SEDDS formulations.- Published
- 2023
- Full Text
- View/download PDF
7. Cutaneous larva migrans in the northeastern US.
- Author
-
Johanis M, Cheema KS, Young PA, Narala S, Saleem A, Novoa RA, and Bae GH
- Subjects
- Humans, Female, Middle Aged, Ivermectin therapeutic use, Skin pathology, Epidermis, Larva Migrans diagnosis, Larva Migrans drug therapy, Larva Migrans epidemiology, Exanthema pathology
- Abstract
Cutaneous larva migrans (CLM) is a dermo-epidermal parasitic infection with a disproportionate incidence in developing countries, particularly in, and near tropical areas. It is characterized by erythematous, twisting, and linear plaques that can migrate to adjacent skin. Herein, we present an otherwise healthy 45-year-old woman who acquired a pruritic, erythematous, and serpiginous rash localized to her right medial ankle during a trip to New England. Oral ivermectin, the preferred first-line treatment for cutaneous larva migrans, was administered in combination with triamcinolone. This was followed by removal of the papular area via punch biopsy; treatment was successful with a one-week recovery. Although cutaneous larva migrans has traditionally been considered a tropical disease, clinicians should be cognizant of its expanding geographic spread.
- Published
- 2023
- Full Text
- View/download PDF
8. Bullous impetigo on a young man's abdomen.
- Author
-
Young PA, Leeolou MC, Narala S, Saleem A, and Bae GH
- Subjects
- Male, Humans, Blister, Abdomen, Impetigo diagnosis, Staphylococcal Infections, Skin Diseases, Autoimmune Diseases
- Abstract
Bullous impetigo is a variant of epidermal infection by Staphylococcus aureus, representing 30% of impetigo cases. Its clinical appearance may mimic certain autoimmune blistering dermatoses and other cutaneous infections, sometimes necessitating careful evaluation. Herein we present a patient with bullous impetigo in a striking and characteristic appearance and briefly overview the approach to diagnosis, treatment, and prevention.
- Published
- 2023
- Full Text
- View/download PDF
9. A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery.
- Author
-
Kolimi P, Narala S, Youssef AAA, Nyavanandi D, and Dudhipala N
- Subjects
- Drug Delivery Systems methods, Porosity, Silicon Dioxide chemistry, Tissue Distribution, Drug Carriers chemistry, Nanoparticles chemistry
- Abstract
Recent advances in drug delivery technologies utilizing a variety of carriers have resulted in a paradigm shift in the current approach to diagnosis and therapy. Mesoporous silica nanoparticles (MSNs) were developed in response to the need for materials with high thermal, chemical, and mechanical properties. The synthesis, ease of surface functionalization, tunable pore size, large surface area, and biocompatibility of MSNs make them useful in a variety of biomedical applications such as drug delivery, theranostics, and stem cell research. In addition, MSNs have a high capability of delivering actives ranging from small molecules such as drugs and amino acids to larger peptides, vaccines, and antibodies in general. Moreover, MSN-based transdermal delivery has sparked a lot of interest because of the increase in drug stability, permeation, and ease of functionalization. The functionalization of MSNs plays an important role in the efficient delivery of therapeutic agents in a highly controlled manner. This review introduced dermal and transdermal drug delivery systems, explained the anatomy of the skin, and summarized different barriers that affect the transdermal delivery of many therapeutic agents. In addition, the fundamentals of MSNs together with their physicochemical properties, synthesis approaches, raw materials used in their fabrication, and factors affecting their physicochemical properties will be covered. Moreover, the applications of MSNs in dermal and transdermal delivery, the biocompatibility of MSNs in terms of toxicity and safety, and biodistribution will be explained with the help of a detailed literature review. The review is covering the current and future perspectives of MSNs in the pharmaceutical field with therapeutic applications., Competing Interests: Competing Interests: The authors have declared that no competing interest exists., (© The author(s).)
- Published
- 2023
- Full Text
- View/download PDF
10. Preparation and in vitro evaluation of hot-melt extruded pectin-based pellets containing ketoprofen for colon targeting.
- Author
-
Narala S, Nyavanandi D, Mandati P, Youssef AAA, Alzahrani A, Kolimi P, Zhang F, and Repka M
- Abstract
This work developed high drug-load pellets for colon targeting in minimal steps by coupling hot-melt extrusion (HME) with a die-surface cutting pelletizer, offering a potential continuous pellet manufacturing process. Ketoprofen (KTP) was selected as a model drug for this study due to its thermal stability and severe upper gastrointestinal side effects. Low and high methoxyl grade pectins were the enzyme-triggered release matrix, and hydroxypropyl methylcellulose (HME 4 M/HME 100LV) was used as a premature release-retarding agent. The powder X-ray diffraction technique and the differential scanning calorimetry results revealed that KTP exists in the solid-solution state within the polymeric matrix after the HME step. The scanning electron micrographs of the fabricated pellets showed a smooth surface without any cracks. The lead formulation showed the lowest premature drug release (∼13%) with an extended KTP release profile over a 24 h period in the presence and absence of the release-triggering enzyme. The lead formulation was stable for 3 months at accelerated stability conditions (40 °C/75 ± 5% RH) concerning drug content, in vitro release, and thermal characteristics. In summary, coupling HME and pelletization processes could be a promising technology for developing colon-targeted drug delivery systems., Competing Interests: The authors believe that there are no conflicts of interest to declare for the research article entitled “Preparation and In vitro Evaluation of Hot-Melt Extruded Pectin-Based Pellets Containing Ketoprofen for Colon Targeting”., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
11. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder in a young woman.
- Author
-
Leeolou MC, Young PA, Saleem A, Narala S, and Bae GH
- Subjects
- Female, Humans, Adult, CD4-Positive T-Lymphocytes, Skin Neoplasms pathology, Lymphoma, T-Cell, Cutaneous pathology, Skin Diseases pathology, Lymphoproliferative Disorders pathology
- Abstract
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (CD4+PCSM-LPD) is a low-grade cutaneous T cell disorder. There is no standardized approach to treatment of CD4+ PCSM-LPD due to its rarity. Herein, we discuss a 33-year-old woman with CD4+PCSM-LPD which resolved after a partial biopsy. We highlight that conservative and local treatment modalities should be considered prior to utilizing more aggressive and invasive treatment options.
- Published
- 2022
- Full Text
- View/download PDF
12. Burning urticarial plaques in a middle-aged woman.
- Author
-
Young PA, Saleem A, Narala S, Dear A, and Bae GH
- Abstract
Competing Interests: None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
13. Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects.
- Author
-
Rangaraj N, Sampathi S, Junnuthula V, Kolimi P, Mandati P, Narala S, Nyavanandi D, and Dyawanapelly S
- Abstract
Among various drug administration routes, oral drug delivery is preferred and is considered patient-friendly; hence, most of the marketed drugs are available as conventional tablets or capsules. In such cases, the administration of drugs with or without food has tremendous importance on the bioavailability of the drugs. The presence of food may increase (positive effect) or decrease (negative effect) the bioavailability of the drug. Such a positive or negative effect is undesirable since it makes dosage estimation difficult in several diseases. This may lead to an increased propensity for adverse effects of drugs when a positive food effect is perceived. However, a negative food effect may lead to therapeutic insufficiency for patients suffering from life-threatening disorders. This review emphasizes the causes of food effects, formulation strategies to overcome the fast-fed variability, and the regulatory aspects of drugs with food effects, which may open new avenues for researchers to design products that may help to eliminate fast-fed variability.
- Published
- 2022
- Full Text
- View/download PDF
14. Evanescent, episodic salmon-colored macules in a young woman.
- Author
-
Leeolou MC, Young PA, Dear AL, Narala S, Saleem A, Rieger KE, and Bae GH
- Abstract
Competing Interests: None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
15. Innovative Treatment Strategies to Accelerate Wound Healing: Trajectory and Recent Advancements.
- Author
-
Kolimi P, Narala S, Nyavanandi D, Youssef AAA, and Dudhipala N
- Subjects
- Bandages, Humans, Skin injuries, Skin Physiological Phenomena, Quality of Life, Wound Healing
- Abstract
Wound healing is highly specialized dynamic multiple phase process for the repair of damaged/injured tissues through an intricate mechanism. Any failure in the normal wound healing process results in abnormal scar formation, and chronic state which is more susceptible to infections. Chronic wounds affect patients' quality of life along with increased morbidity and mortality and are huge financial burden to healthcare systems worldwide, and thus requires specialized biomedical intensive treatment for its management. The clinical assessment and management of chronic wounds remains challenging despite the development of various therapeutic regimens owing to its painstakingly long-term treatment requirement and complex wound healing mechanism. Various conventional approaches such as cell therapy, gene therapy, growth factor delivery, wound dressings, and skin grafts etc., are being utilized for promoting wound healing in different types of wounds. However, all these abovementioned therapies are not satisfactory for all wound types, therefore, there is an urgent demand for the development of competitive therapies. Therefore, there is a pertinent requirement to develop newer and innovative treatment modalities for multipart therapeutic regimens for chronic wounds. Recent developments in advanced wound care technology includes nanotherapeutics, stem cells therapy, bioengineered skin grafts, and 3D bioprinting-based strategies for improving therapeutic outcomes with a focus on skin regeneration with minimal side effects. The main objective of this review is to provide an updated overview of progress in therapeutic options in chronic wounds healing and management over the years using next generation innovative approaches. Herein, we have discussed the skin function and anatomy, wounds and wound healing processes, followed by conventional treatment modalities for wound healing and skin regeneration. Furthermore, various emerging and innovative strategies for promoting quality wound healing such as nanotherapeutics, stem cells therapy, 3D bioprinted skin, extracellular matrix-based approaches, platelet-rich plasma-based approaches, and cold plasma treatment therapy have been discussed with their benefits and shortcomings. Finally, challenges of these innovative strategies are reviewed with a note on future prospects.
- Published
- 2022
- Full Text
- View/download PDF
16. Nontender white papule of the areola in a middle-aged female.
- Author
-
Young PA, Narala S, Brown RA, Saleem A, Rieger KE, and Bae GH
- Abstract
Competing Interests: None disclosed.
- Published
- 2022
- Full Text
- View/download PDF
17. Abnormal B-cell development in TIMP-deficient bone marrow.
- Author
-
Weiss A, Saw S, Aiken A, Aliar K, Shao YW, Fang H, Narala S, Shetty R, Waterhouse PD, and Khokha R
- Subjects
- Animals, B-Lymphocytes, Hematopoiesis, Mice, Tissue Inhibitor of Metalloproteinases genetics, Bone Marrow, Bone Marrow Cells
- Abstract
Bone marrow (BM) is the primary site of hematopoiesis and is responsible for a lifelong supply of all blood cell lineages. The process of hematopoiesis follows key intrinsic programs that also integrate instructive signals from the BM niche. First identified as an erythropoietin-potentiating factor, the tissue inhibitor of metalloproteinase (TIMP) protein family has expanded to 4 members and has widely come to be viewed as a classical regulator of tissue homeostasis. By virtue of metalloprotease inhibition, TIMPs not only regulate extracellular matrix turnover but also control growth factor bioavailability. The 4 mammalian TIMPs possess overlapping enzyme-inhibition profiles and have never been studied for their cumulative role in hematopoiesis. Here, we show that TIMPs are critical for postnatal B lymphopoiesis in the BM. TIMP-deficient mice have defective B-cell development arising at the pro-B-cell stage. Expression analysis of TIMPless hematopoietic cell subsets pointed to an altered B-cell program in the Lineage-Sca-1+c-Kit+ (LSK) cell fraction. Serial and competitive BM transplants identified a defect in TIMP-deficient hematopoietic stem and progenitor cells for B lymphopoiesis. In parallel, reverse BM transplants uncovered the extrinsic role of stromal TIMPs in pro- and pre-B-cell development. TIMP deficiency disrupted CXCL12 localization to LepR+ cells, and increased soluble CXCL12 within the BM niche. It also compromised the number and morphology of LepR+ cells. These data provide new evidence that TIMPs control the cellular and biochemical makeup of the BM niche and influence the LSK transcriptional program required for optimal B lymphopoiesis., (© 2021 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation.
- Author
-
Eedara BB, Nyavanandi D, Narala S, Veerareddy PR, and Bandari S
- Abstract
The objective of this study was to enhance dissolution and permeation of a low soluble, absorbable fexofenadine hydrochloride (FFH) by preparing solid dispersions using polyethylene glycol 20,000 (PEG 20,000) and poloxamer 188 as carriers. The phase solubility measurement for the supplied FFH revealed a linear increase in the solubility of fexofenadine with increasing carrier concentration in water (1.45 mg/mL to 11.78 mg/mL with 0% w/v to 30% w/v PEG 20,000; 1.45 mg/mL to 12.27 mg/mL with 0% w/v to 30% w/v poloxamer 188). To select the appropriate drug carrier concentration, a series of solid dispersions were prepared in the drug carrier weight ratios of 1:1, 1:2 and 1:4 by fusion method. The solid dispersions composed of drug carrier at 1:4 weight ratio showed highest dissolution with the time required for the release of 50% of the drug <15 min compared to the supplied FFH (>120 min). The intestinal absorption study presented a significant improvement in the absorption of drug from the solid dispersions composed of poloxamer 188 than PEG 20,000. In summary, the solid dispersions of FFH prepared using PEG 20,000 and poloxamer 188 demonstrated improved dissolution and absorption than supplied FFH and could be used to improve the oral bioavailability of fexofenadine.
- Published
- 2021
- Full Text
- View/download PDF
19. Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome.
- Author
-
Farooq S, Narala S, and Pacha O
- Published
- 2020
- Full Text
- View/download PDF
20. HIV patient with painless bilateral external ear nodules.
- Author
-
McNally M, Narala S, and Koshelev M
- Published
- 2020
- Full Text
- View/download PDF
21. CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.
- Author
-
Tang Q, Lu J, Zou C, Shao Y, Chen Y, Narala S, Fang H, Xu H, Wang J, Shen J, and Khokha R
- Subjects
- Animals, Carcinogenesis genetics, Cell Line, Tumor, Cell Movement genetics, Cell Proliferation genetics, Female, Gene Expression Regulation, Neoplastic genetics, Humans, JNK Mitogen-Activated Protein Kinases metabolism, Lung Neoplasms secondary, Mice, Mice, Inbred BALB C, Mice, Nude, Neoplasm Invasiveness genetics, Neoplasm Transplantation, Osteogenesis genetics, RNA Interference, RNA, Small Interfering genetics, Transplantation, Heterologous, Bone Neoplasms genetics, Bone Neoplasms pathology, Cadherins biosynthesis, Cadherins genetics, Osteosarcoma genetics, Osteosarcoma pathology
- Abstract
The era of cancer genomics now provides an opportunity to discover novel determinants of osteosarcoma (OS), the most common primary bone cancer in children and adolescents known for its poor prognosis due to lung metastasis. Here, we identify CDH4 amplification in 43.6% of human osteosarcoma using array CGH and demonstrate its critical role in osteosarcoma development and progression. Gain or loss-of-function of CDH4, which encodes R-cadherin, causally impacts multiple features of human OS cells including cell migration and invasion, osteogenic differentiation, and stemness. CDH4 overexpression activates c-Jun via the JNK pathway, while CDH4 knockdown suppresses both tumor xenograft growth and lung colonization. In OS patient specimens, high CDH4 expression associates with lung metastases and poor prognosis. Collectively, our bioinformatics, functional, molecular, and clinical analyses uncover an oncogenic function of CDH4 in osteosarcoma and its relationship with patient outcome.
- Published
- 2018
- Full Text
- View/download PDF
22. Characteristics of research tracks in dermatology residency programs: a national survey.
- Author
-
Narala S, Loh T, Shinkai K, and Paravar T
- Subjects
- Surveys and Questionnaires, United States, Biomedical Research education, Dermatology education, Internship and Residency
- Abstract
Pursuing research is encouraged in dermatology residency programs. Some programs offer specific research or investigative tracks. Currently, there is little data on the structure or scope of research tracks in dermatology residency programs. An anonymous online survey was distributed to the Association of Professors of Dermatology listserve in 2016. Program directors of dermatology residency programs in the United States were asked to participate and 38 of the 95 program directors responded. The survey results confirmed that a 2+2 research track, which is two years of clinical training followed by two years of research, was the most common investigator trackmodel and may promote an academic career at the resident's home institution. Further studies will help determine the most effective research track models to promote long-term outcomes.
- Published
- 2017
23. Adult Atopic Dermatitis with Comorbid Atopic Disease is Associated with Increased Risk of Infections: A Population-Based Cross-Sectional Study.
- Author
-
Narala S and Hata TR
- Abstract
Introduction: Atopic dermatitis (AD) is related to other atopic diseases asthma and allergic rhinitis. It is known that those with asthma or allergic rhinitis have impaired immune responses that may predispose them to infections. This study sought to determine whether adult AD is associated with systemic infections, and whether association is strengthened in those with AD plus another atopic disease., Methods: This cross-sectional study obtained information from adults in the 2010 and the 2012 National Health Interview Survey (NHIS). The primary exposure was history of AD without or with an additional atopic disease, asthma or allergic rhinitis. Self-reported systemic infections were the primary outcomes. Survey logistic regression was performed and adjusted odds ratios (aOR) reported., Results: AD in NHIS 2010 was associated with increased risk of sinusitis [aOR (95% CIs): 1.65 (1.42, 1.91), P < 0.001], head or chest cold [1.31 (1.12, 1.52), P < 0.001], and gastrointestinal illness [2.39 (1.97, 2.89), P < 0.001], and in NHIS 2012, pneumonia/influenza [1.73 (1.54, 1.95), P < 0.001], strep throat/tonsillitis [1.72 (1.54, 1.92), P < 0.001], sinusitis [1.77 (1.54, 2.02), P < 0.001], head or chest cold [1.49 (1.33, 1.67), P < 0.001], and infectious disease [2.66 (2.20, 3.21), P < 0.001]. An increase in atopic disease mirrored an increase in number of infectious outcomes and was statistically significant in the combined dataset (P < 0.001)., Conclusion: The associations between AD and AD plus another atopic disease with systemic infections suggest that an underlying immune defect may be contributing to microbial susceptibility. Further studies are warranted to understand the burden of infectious disease in this population.
- Published
- 2017
- Full Text
- View/download PDF
24. Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review.
- Author
-
Narala S and Cohen PR
- Subjects
- Aged, 80 and over, Humans, Keratosis, Seborrheic diagnosis, Keratosis, Seborrheic pathology, Lymphoma, T-Cell, Cutaneous complications, Lymphoma, T-Cell, Cutaneous diagnosis, Lymphoma, T-Cell, Cutaneous pathology, Male, Mycosis Fungoides diagnosis, Mycosis Fungoides pathology, Skin Neoplasms diagnosis, Skin Neoplasms pathology, Keratosis, Seborrheic etiology, Mycosis Fungoides complications, Skin Neoplasms complications
- Abstract
Background: The sign of Leser-Trélat is characterizedby the sudden appearance of seborrheic keratosesassociated with an underlying malignancy., Objectives: An elderly man who developed multiple new-onsetseborrheic keratoses temporally associated witha diagnosis of mycosis fungoides is described andlymphoma-associated Leser-Trélat sign is reviewed., Methods: Pubmed was used to search the followingterms: cutaneous T-cell lymphoma, Leser-Trélat,leukemia, lymphoma, mycosis fungoides, and Sézarysyndrome. Papers with these terms and referencescited within these papers were reviewed., Results: An 84-year-old man developed multiple seborrheickeratoses temporally associated with a diagnosisof mycosis fungoides is presented. He was treatedwith bexarotene and achieved clinical remission;the number of seborrheic keratoses also decreased.Lymphoma-associated Leser-Trélat sign has beenobserved not only with mycosis fungoides but alsoother lymphomas and leukemias., Conclusions: Thesign of Leser-Trélat is predominantly associated withsolid organ adenocarcinomas. Albeit less common, aneruptive onset of seborrheic keratoses can also occurin association with hematopoietic malignancies.
- Published
- 2017
25. Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression.
- Author
-
Nakatsuji T, Chen TH, Two AM, Chun KA, Narala S, Geha RS, Hata TR, and Gallo RL
- Subjects
- Animals, Cells, Cultured, Cytokines genetics, DNA genetics, Dermatitis, Atopic microbiology, Dermatitis, Atopic pathology, Epidermis immunology, Epidermis pathology, Filaggrin Proteins, Gene Expression Regulation, Humans, Male, Mice, Mice, Knockout, Signal Transduction, Staphylococcus aureus immunology, Antibodies, Bacterial immunology, Cytokines biosynthesis, Dermatitis, Atopic immunology, Epidermis metabolism, Staphylococcus aureus isolation & purification
- Abstract
Patients with atopic dermatitis (AD) have an abnormal skin barrier and are frequently colonized by S. aureus. In this study we investigated if S. aureus penetrates the epidermal barrier of subjects with AD and sought to understand the mechanism and functional significance of this entry. S. aureus was observed to be more abundant in the dermis of lesional skin from AD patients. Bacterial entry past the epidermis was observed in cultured human skin equivalents and in mice but was found to be increased in the skin of cathelicidin knockout and ovalbumin-sensitized filaggrin mutant mice. S. aureus penetration through the epidermis was dependent on bacterial viability and protease activity, because killed bacteria and a protease-null mutant strain of S. aureus were unable to penetrate. Entry of S. aureus directly correlated with increased expression of IL-4, IL-13, IL-22, thymic stromal lymphopoietin, and other cytokines associated with AD and with decreased expression of cathelicidin. These data illustrate how abnormalities of the epidermal barrier in AD can alter the balance of S. aureus entry into the dermis and provide an explanation for how such dermal dysbiosis results in increased inflammatory cytokines and exacerbation of disease., Competing Interests: The authors state no conflict of interest., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
26. Basal Cell Carcinoma of the Umbilicus: A Comprehensive Literature Review.
- Author
-
Narala S and Cohen PR
- Abstract
Basal cell carcinoma (BCC) typically occurs in sun-exposed sites. Only 16 individuals with umbilical BCC have been described in the literature, and the characteristics of patients with umbilical BCC are summarized. PubMed was used to search the following terms: abdomen, basal cell carcinoma, basal cell nevus syndrome, and umbilicus. Papers with these terms and references cited within these papers were reviewed. BCC of the umbilicus has been reported in five men and 11 women; one man had two tumors. Two patients had basal cell nevus syndrome (BCNS). Other risk factors for BCC were absent. The tumor most commonly demonstrated nodular histology (64%, 9/14); superficial and fibroepithelioma of Pinkus variants were noted in three and two patients, respectively. The tumor was pigmented in eight individuals. Treatment was conventional surgical excision (87%, 13/15) or Mohs micrographic surgery (13%, 2/15); either adjuvant laser ablation or radiotherapy was performed in two patients. The prognosis after treatment was excellent with no recurrence or metastasis (100%, 16/16). In conclusion, BCC of the umbilicus is rare. It usually presents as a tumor with a non-aggressive histologic subtype in an individual with no risk factors for this malignancy. There has been no recurrence or metastasis following excision of the cancer., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
27. RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1.
- Author
-
Joshi PA, Waterhouse PD, Kannan N, Narala S, Fang H, Di Grappa MA, Jackson HW, Penninger JM, Eaves C, and Khokha R
- Subjects
- Animals, Cell Proliferation genetics, Female, Humans, Mammary Glands, Animal growth & development, Mice, Receptor Activator of Nuclear Factor-kappa B antagonists & inhibitors, Thrombospondins biosynthesis, Wnt Signaling Pathway genetics, Mammary Glands, Animal metabolism, Receptor Activator of Nuclear Factor-kappa B genetics, Stem Cells cytology, Thrombospondins genetics
- Abstract
Systemic and local signals must be integrated by mammary stem and progenitor cells to regulate their cyclic growth and turnover in the adult gland. Here, we show RANK-positive luminal progenitors exhibiting WNT pathway activation are selectively expanded in the human breast during the progesterone-high menstrual phase. To investigate underlying mechanisms, we examined mouse models and found that loss of RANK prevents the proliferation of hormone receptor-negative luminal mammary progenitors and basal cells, an accompanying loss of WNT activation, and, hence, a suppression of lobuloalveologenesis. We also show that R-spondin1 is depleted in RANK-null progenitors, and that its exogenous administration rescues key aspects of RANK deficiency by reinstating a WNT response and mammary cell expansion. Our findings point to a novel role of RANK in dictating WNT responsiveness to mediate hormone-induced changes in the growth dynamics of adult mammary cells., (Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.